植体周围炎市场－全球产业规模、份额、趋势、机会和预测，按类型（非手术、手术）、按最终用户（牙科诊所、医院）、按地区和竞争细分，2020-2030 年预测

2024 年全球植体周围炎市值为 11.058 亿美元，预计在预测期内将出现令人印象深刻的成长，到 2030 年的复合年增长率为 8.15%。植体周围炎是一种影响植牙周围组织的发炎性疾病。它有点类似牙周炎，牙周炎是一种影响天然牙齿周围组织的发炎性疾病。植体周围炎具体涉及牙种植体周围软组织和硬组织的发炎和感染，如果不及时治疗，会导致支撑骨逐渐丧失，并可能导致植体失败。植体周围炎的常见征兆和症状包括牙龈出血、肿胀、发红、流脓、植体周围疼痛或不适、植体移动或鬆动，以及在严重的情况下，可见的牙龈萎缩和植体线头暴露。多种因素会增加植体周围炎的风险，包括口腔卫生不良、吸烟、牙​​周病史（牙龈疾病）、糖尿病、某些药物以及缺乏定期牙科检查和保养。根据植体周围组织和骨质损失的程度，植体周围炎通常分为从轻度到重度几个阶段。早期发现和介入对于有效治疗植体周围炎至关重要。

关键市场驱动因素

植体周围疾病盛行率上升

主要市场挑战

治疗费用

主要市场趋势

治疗方式

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：植体周围炎市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 按类型（非手术、手术）
  • 按最终使用者（牙科诊所、医院）
  • 按地区
  • 按公司分类（2024）
• 市场地图

第六章：北美植体周围炎市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 加拿大
  • 墨西哥

第七章：欧洲植体周围炎市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 英国
  • 义大利
  • 法国
  • 西班牙

第八章：亚太植体周围炎市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：南美洲植体周围炎市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 阿根廷
  • 哥伦比亚

第十章：中东和非洲植体周围炎市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 最新动态
• 产品发布
• 併购

第 13 章：全球植体周围炎市场：SWOT 分析

第 14 章：竞争格局

• Pfizer Inc.
• Cadila Pharmaceuticals Ltd.
• RN Laboratories Pvt. Ltd.
• Basic Pharma Life Science Pvt. Ltd
• Prachi Pharmaceuticals Private Limited
• Geistlich Pharma Inc.
• Healthy Life Pharma.

第 15 章：策略建议

第16章调查会社について・免责事项

Global Peri-implantitis Market was valued at USD 1105.80 Million in 2024 and is anticipated to witness an impressive growth in the forecast period with a CAGR of 8.15% through 2030. Peri-implantitis is an inflammatory condition that affects the tissues surrounding dental implants. It is somewhat analogous to periodontitis, which is an inflammatory disease that affects the tissues surrounding natural teeth. Peri-implantitis specifically involves the inflammation and infection of the soft and hard tissues around a dental implant, which can lead to progressive loss of supporting bone and potentially result in implant failure if left untreated. Common signs and symptoms of peri-implantitis may include bleeding gums, swelling, redness, pus discharge, pain or discomfort around the implant, mobility or loosening of the implant, and, in advanced cases, visible gum recession and exposed implant threads. Several factors can increase the risk of developing peri-implantitis, including poor oral hygiene, smoking, a history of periodontal disease (gum disease), diabetes, certain medications, and a lack of regular dental check-ups and maintenance. Peri-implantitis is often categorized into stages, ranging from mild to severe, based on the extent of tissue and bone loss around the implant. Early detection and intervention are crucial for managing peri-implantitis effectively.

Key Market Drivers

Rising Prevalence of Peri-implant Diseases

The rising prevalence of peri-implant diseases is a critical market driver that significantly influences the growth of the Global Peri-implantitis Market. Research indicates that peri-implantitis affects approximately 7% to 28% of patients with dental implants, while peri-implant mucositis is observed in 27% to 63% of cases. Although the World Health Organization (WHO) has not established specific guidelines on peri-implant disease incidence, its initiatives emphasize overall oral health management and the importance of preventive care in implant dentistry. Peri-implant diseases, including peri-implant mucositis and peri-implantitis, are becoming increasingly common due to the widespread adoption of dental implants. This growing burden has created a rising demand for preventive, diagnostic, and treatment solutions, fueling market expansion. The global surge in dental implant procedures has led to a proportional increase in peri-implant diseases. While dental implants are a preferred solution for tooth replacement due to their durability and functionality, they are also susceptible to infection and inflammation, which can lead to peri-implant diseases. The more implants placed, the higher the number of patients experiencing peri-implant conditions, thereby driving the demand for effective peri-implantitis treatment solutions.

Key Market Challenges

Cost of Treatment

Peri-implantitis treatment can be costly, particularly in cases where surgical interventions, such as open flap debridement, bone grafting, or implant removal and replacement, are required. The expenses associated with these procedures, including professional fees, facility charges, and post-operative care, can add up quickly. Dental insurance plans often do not provide comprehensive coverage for peri-implantitis treatment. This lack of coverage can place a significant financial burden on patients, making treatment less accessible. Many peri-implantitis treatment expenses are out-of-pocket costs for patients. This includes the cost of diagnostic tests, consultations with specialists, surgical procedures, medications, and follow-up care. Peri-implantitis treatment may require multiple treatment sessions and follow-up appointments, which can further increase the overall cost for patients. The cost of peri-implantitis treatment can vary widely depending on the severity of the condition, the complexity of the procedures required, the geographic location of the dental practice, and the expertise of the treating professionals. Patients with limited financial resources may find it challenging to afford the upfront costs associated with peri-implantitis treatment. This can lead to delays in seeking care or a reluctance to pursue treatment altogether. High treatment costs can have a significant impact on the quality of life of patients with peri-implantitis. They may have to make difficult choices between their oral health and other essential expenses. Patients in underserved or remote areas may have limited access to specialized dental professionals with expertise in peri-implantitis treatment. Traveling long distances to seek care can add to the overall cost.

Key Market Trends

Treatment Modalities

Surgical treatment modalities, such as open flap debridement, bone grafting, and guided tissue regeneration, continue to be prominent in peri-implantitis management. Advancements in surgical techniques and materials enhance their effectiveness. Laser technology, including diode lasers and erbium lasers, has gained popularity for the treatment of peri-implantitis. Lasers can effectively remove infected tissue, disinfect implant surfaces, and promote tissue regeneration. Various antimicrobial agents, including topical antibiotics and antiseptics, are used in the treatment of peri-implantitis to control bacterial infections. Research is ongoing to develop more targeted and effective antimicrobial treatments. Implantoplasty involves the mechanical smoothing of rough implant surfaces to remove biofilm and encourage re-osseointegration. This minimally invasive approach is gaining attention as a potential treatment option. Non-surgical modalities, such as mechanical debridement and air abrasive therapy, are considered for less severe cases of peri-implantitis. These methods aim to remove biofilm and calculus without the need for surgical intervention. Personalized treatment plans based on the specific needs of each patient are becoming more common. This includes considering factors like the extent of tissue loss, bone quality, and patient health status. Biomaterials, growth factors, and tissue engineering scaffolds are being explored to enhance tissue regeneration around dental implants affected by peri-implantitis. Telehealth platforms and teledentistry services are being utilized for remote consultations, monitoring, and follow-up care, making peri-implantitis treatment more accessible to patients. Research into smart implants with integrated sensors and monitoring capabilities is ongoing. These implants may provide real-time data on the health of the implant and surrounding tissues, aiding in treatment decisions.

Key Market Players

• Pfizer Inc.
• Cadila Pharmaceuticals Ltd.
• R.N. Laboratories Pvt. Ltd.
• Basic Pharma Life Science Pvt. Ltd
• Prachi Pharmaceuticals Private Limited
• Geistlich Pharma Inc.
• Healthy Life Pharma

Report Scope:

In this report, the Global Peri-implantitis Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Peri-implantitis Market, By Type:

• Non-Surgical
• Surgical

Peri-implantitis Market, By End-User:

• Dental Clinics
• Hospitals

Peri-implantitis Market, By region:

• North America
  • United States
  • Canada
  • Mexico
• Asia-Pacific
  • China
  • India
  • South Korea
  • Australia
  • Japan
• Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Italy
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Peri-implantitis Market.

Available Customizations:

Global Peri-implantitis Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Peri-implantitis Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Non-Surgical, Surgical)
  • 5.2.2. By End-User (Dental Clinics, Hospitals)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Peri-implantitis Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By End User
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Peri-implantitis Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By End User
  • 6.3.2. Canada Peri-implantitis Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By End User
  • 6.3.3. Mexico Peri-implantitis Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By End User

7. Europe Peri-implantitis Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By End User
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Peri-implantitis Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By End User
  • 7.3.2. United Kingdom Peri-implantitis Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By End User
  • 7.3.3. Italy Peri-implantitis Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By End User
  • 7.3.4. France Peri-implantitis Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By End User
  • 7.3.5. Spain Peri-implantitis Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By End User

8. Asia-Pacific Peri-implantitis Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By End User
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Peri-implantitis Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By End User
  • 8.3.2. India Peri-implantitis Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By End User
  • 8.3.3. Japan Peri-implantitis Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By End User
  • 8.3.4. South Korea Peri-implantitis Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By End User
  • 8.3.5. Australia Peri-implantitis Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By End User

9. South America Peri-implantitis Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By End User
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Peri-implantitis Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By End User
  • 9.3.2. Argentina Peri-implantitis Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By End User
  • 9.3.3. Colombia Peri-implantitis Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By End User

10. Middle East and Africa Peri-implantitis Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By End User
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Peri-implantitis Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By End User
  • 10.3.2. Saudi Arabia Peri-implantitis Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By End User
  • 10.3.3. UAE Peri-implantitis Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Peri-implantitis Market: SWOT Analysis

14. Competitive Landscape

• 14.1. Pfizer Inc.
  • 14.1.1. Business Overview
  • 14.1.2. Product & Service Offerings
  • 14.1.3. Recent Developments
  • 14.1.4. Financials (If Listed)
  • 14.1.5. Key Personnel
  • 14.1.6. SWOT Analysis
• 14.2. Cadila Pharmaceuticals Ltd.
• 14.3. R.N. Laboratories Pvt. Ltd.
• 14.4. Basic Pharma Life Science Pvt. Ltd
• 14.5. Prachi Pharmaceuticals Private Limited
• 14.6. Geistlich Pharma Inc.
• 14.7. Healthy Life Pharma.

15. Strategic Recommendations

16. About Us & Disclaimer